Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Reduction in non-protein respiratory quotient is related to overall survival after hepatocellular carcinoma treatment.

Saito M, Seo Y, Yano Y, Momose K, Hirano H, Yoshida M, Azuma T.

PLoS One. 2013;8(3):e55441. doi: 10.1371/journal.pone.0055441. Epub 2013 Mar 8.

PMID:
23520445
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.

Saito M, Seo Y, Yano Y, Miki A, Yoshida M, Azuma T.

J Gastroenterol. 2012 Jun;47(6):704-14. doi: 10.1007/s00535-012-0535-x. Epub 2012 Feb 18.

PMID:
22350695
[PubMed - indexed for MEDLINE]
3.

Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.

Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.

J Gastroenterol Hepatol. 2008 Mar;23(3):482-90. Epub 2007 Dec 13.

PMID:
18086115
[PubMed - indexed for MEDLINE]
4.

Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.

Biselli M, Andreone P, Gramenzi A, Trevisani F, Cursaro C, Rossi C, Ricca Rosellini S, Cammà C, Lorenzini S, Stefanini GF, Gasbarrini G, Bernardi M.

Clin Gastroenterol Hepatol. 2005 Sep;3(9):918-25.

PMID:
16234031
[PubMed - indexed for MEDLINE]
5.

The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.

Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M.

Cancer. 2000 Dec 15;89(12):2606-12.

PMID:
11135222
[PubMed - indexed for MEDLINE]
6.

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.

Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y; Liver Cancer Study Group of Japan.

Gastroenterology. 2006 Aug;131(2):461-9.

PMID:
16890600
[PubMed - indexed for MEDLINE]
7.

Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.

Hsin IF, Hsu CY, Huang HC, Huang YH, Lin HC, Lee RC, Chiang JH, Lee FY, Huo TI, Lee SD.

J Clin Gastroenterol. 2011 Jul;45(6):556-62. doi: 10.1097/MCG.0b013e318210ff17.

PMID:
21666547
[PubMed - indexed for MEDLINE]
8.

Alteration of non-protein respiratory quotient after hepatocellular carcinoma treatment can be related to des-γ-carboxy prothrombin before treatment.

Saito M, Seo Y, Yano Y, Miki A, Momose K, Hirano H, Yoshida M, Azuma T.

Springerplus. 2012 Nov 29;1:55. doi: 10.1186/2193-1801-1-55. eCollection 2012.

PMID:
23961374
[PubMed]
Free PMC Article
9.
10.

Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.

Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S, Mori M.

Eur J Surg Oncol. 2006 Sep;32(7):773-9. Epub 2006 Jun 21.

PMID:
16797156
[PubMed - indexed for MEDLINE]
11.

Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization.

Ji SK, Cho YK, Ahn YS, Kim MY, Park YO, Kim JK, Kim WT.

Korean J Radiol. 2008 Nov-Dec;9(6):534-40. doi: 10.3348/kjr.2008.9.6.534.

PMID:
19039270
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment.

Saito M, Seo Y, Yano Y, Miki A, Yoshida M, Azuma T.

J Gastroenterol. 2012 Oct;47(10):1134-42. doi: 10.1007/s00535-012-0577-0. Epub 2012 Mar 24.

PMID:
22441533
[PubMed - indexed for MEDLINE]
13.

[Efficacy of transcatheter arterial chemoembolization combined thalidomide on hepatocellular carcinoma: a controlled randomized trial].

Hao MZ, Lin HL, Chen Q, Wu H, Yu WC, Chen TG.

Ai Zheng. 2007 Aug;26(8):861-5. Chinese.

PMID:
17697548
[PubMed - indexed for MEDLINE]
14.

An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.

Pinato DJ, Sharma R.

Transl Res. 2012 Aug;160(2):146-52. doi: 10.1016/j.trsl.2012.01.011. Epub 2012 Jan 30.

PMID:
22677364
[PubMed - indexed for MEDLINE]
15.

Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence.

Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J.

J Surg Oncol. 2000 Feb;73(2):109-14.

PMID:
10694648
[PubMed - indexed for MEDLINE]
16.

[The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma].

Zhang Z, Wu M, Liu Q.

Zhonghua Zhong Liu Za Zhi. 1999 May;21(3):214-6. Chinese.

PMID:
11776840
[PubMed - indexed for MEDLINE]
17.

[Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC)].

Herber SC, Otto G, Woerns M, Moench C, Kanzler S, Junginger T, Schneider J, Schuchmann M, Kummer I, Manzl N, Düber C, Pitton MB.

Rofo. 2007 Mar;179(3):289-99. German.

PMID:
17325996
[PubMed - indexed for MEDLINE]
18.

Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?

Harada T, Matsuo K, Inoue T, Tamesue S, Inoue T, Nakamura H.

Ann Surg. 1996 Jul;224(1):4-9.

PMID:
8678616
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.

Hsu CY, Huang YH, Su CW, Lin HC, Chiang JH, Lee PC, Lee FY, Huo TI, Lee SD.

Liver Int. 2010 Jan;30(1):77-84. doi: 10.1111/j.1478-3231.2009.02128.x. Epub 2009 Oct 8.

PMID:
19818004
[PubMed - indexed for MEDLINE]
20.

Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.

Cho HS, Seo JW, Kang Y, Bae EJ, Kim HJ, Chang SH, Park DJ.

Clin Exp Nephrol. 2011 Oct;15(5):714-9. doi: 10.1007/s10157-011-0470-9. Epub 2011 Jun 23.

PMID:
21695415
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk